Genaissance Pharmaceuticals, Inc.
- 1 March 2002
- journal article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 3 (2) , 273-276
- https://doi.org/10.1517/14622416.3.2.273
Abstract
Genaissance Pharmaceuticals, Inc. (Nasdaq: GNSC) is the world leader in the discovery and use of gene variation for the development of personalized medicines. In addition, the company has establish...Keywords
This publication has 2 references indexed in Scilit:
- Haplotype Variation and Linkage Disequilibrium in 313 Human GenesScience, 2001
- Complex promoter and coding region β 2 -adrenergic receptor haplotypes alter receptor expression and predict in vivo responsivenessProceedings of the National Academy of Sciences, 2000